RC
RCUS
Market ClosedArcus Biosciences, Inc.
US
601 employees
CEO: Terry J. Rosen
Founded: 2018
$28.42
+$0.00(+NaN%)
Market Cap
2.86B
Beta
0.80
52W Range
N/A
Dividend Yield
0.00%
RCUS Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for RCUS built from valuation, fundamentals, sentiment, and risk models
Investment Signal
Strong SellPass %
42.86%
Score
3/7
Fair Value Estimate
Cash flow analysis • Multiple methods
-$38.83
AI Price Target
Machine learning • Price prediction
$38.13
Market Sentiment
News & social media analysis
0.00
Value Investor Price
Classic value analysis
$0.00
Financial Health
Bankruptcy risk assessment
0.54
Quality Score
Financial strength rating
1.00
AI Investment Grade
Deep analysis of filings & news
75.00
Key Investment Highlights
Important factors affecting RCUS investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
28.21% Poor
Conditions Met
11.00/39.00
Due Diligence Score
28.21%Due Diligence Conditions
Investment analysis conditions and results
Fail | |
Pass | |
Fail | |
Fail | |
Pass | |
Fail |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for RCUS
No recent news available for RCUS
Core Financials
Loading financial data for RCUS...
Explore RCUS
RCUS in the Healthcare
Mid Cap